<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9974401" created="28/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9974401</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="oleic_acid" sem="Lipid">Oleic acid</term> inhibits <term id="T2" lex="endothelial_activation" sem="Other">endothelial activation</term> : A direct vascular <term id="T3" lex="antiatherogenic_mechanism" sem="Other">antiatherogenic mechanism</term> of a <term id="T4" lex="nutritional_component" sem="Other">nutritional component</term> in the <term id="T5" lex="mediterranean_diet" sem="Other">mediterranean diet</term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="T2"/>
<cause idref="T1"/>
<clue>Oleic acid <clueType>inhibits</clueType> endothelial activation : A direct <clueLoc>vascular</clueLoc> antiatherogenic mechanism of a nutritional component in the mediterranean diet.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Because <term id="T6" lex="oleic_acid" sem="Lipid">oleic acid</term> is implicated in the <term id="T7" lex="antiatherogenic_effect" sem="Other">antiatherogenic effects</term> attributed to the <term id="T8" lex="Mediterranean_diet" sem="Other">Mediterranean diet</term>, we investigated whether this <term id="T9" lex="fatty_acid" sem="Lipid">fatty acid</term> can modulate <term id="T10" lex="endothelial_activation" sem="Other">endothelial activation</term>, ie, the concerted expression of <term id="T11" lex="gene_product" sem="Protein_family_or_group">gene products</term> involved in <term id="T12" lex="leukocyte_recruitment" sem="Other"><term id="A1" sem="Cell_natural">leukocyte</term> recruitment</term> and early <term id="T13" lex="atherogenesis" sem="Other">atherogenesis</term>.</sentence>
<event KT="Investigation" id="E2" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T6"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we <clueKT>investigated</clueKT> whether <corefCause>this fatty acid</corefCause> can <clueType>modulate</clueType> endothelial activation, ie, the concerted expression of gene products involved in leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Investigation" id="E3" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T6"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we <clueKT>investigated</clueKT> whether <corefCause>this fatty acid</corefCause> can <clueType>modulate</clueType> endothelial activation, ie, the concerted expression of gene products involved in leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T11"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we investigated whether this fatty acid can modulate endothelial activation, ie, the concerted <clueType>expression</clueType> <linkTheme>of</linkTheme> gene products involved in leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we investigated whether this fatty acid can modulate endothelial activation, ie, the <clueType>concerted</clueType> expression of gene products involved in leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Other" id="E7">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T11"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we investigated whether this fatty acid can modulate endothelial activation, ie, the concerted expression of gene products <clueType>involved</clueType> <linkTheme>in</linkTheme> leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="T13"/>
<cause idref="T11"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we investigated whether this fatty acid can modulate endothelial activation, ie, the concerted expression of gene products <clueType>involved</clueType> <linkTheme>in</linkTheme> leukocyte recruitment and early atherogenesis.</clue>
</event>
<event KT="Other" id="E9">
<type class="Cell_adhesion"/>
<theme idref="A1"/>
<clue>Because oleic acid is implicated in the antiatherogenic effects attributed to the Mediterranean diet, we investigated whether this fatty acid can modulate endothelial activation, ie, the concerted expression of gene products involved in leukocyte <clueType>recruitment</clueType> and early atherogenesis.</clue>
</event>
<sentence id="S3">We incubated <term id="T14" lex="sodium_oleate" sem="Organic_compound_other">sodium oleate</term> with <term id="T15" lex="human_umbilical_vein_endothelial_cell" sem="Cell_natural">human umbilical vein endothelial cells</term> for 0 to 72 hours, followed by coincubation of <term id="T16" lex="oleate" sem="Organic_compound_other">oleate</term> with <term id="T17" lex="human_recombinant_tumor_necrosis_factor" sem="Protein_molecule">human recombinant tumor necrosis factor</term>, <term id="T18" lex="interleukin_(IL)-1alpha" sem="Protein_molecule">interleukin (IL)-1alpha</term>, <term id="T19" lex="IL-1beta" sem="Protein_molecule">IL-1beta</term>, <term id="T20" lex="IL-4" sem="Protein_molecule">IL-4</term>, <term id="T21" lex="Escherichia_coli_lipopolysaccharide" sem="Lipid">Escherichia coli lipopolysaccharide</term> (<term id="T22" lex="LPS" sem="Lipid">LPS</term>), or <term id="T23" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term> for a further 6 to 24 hours.</sentence>
<event KT="Method" id="E10">
<type class="Artificial_process"/>
<theme idref="T14"/>
<theme idref="T15"/>
<clue>We <clueType>incubated</clueType> sodium oleate <linkTheme>with</linkTheme> human umbilical vein endothelial cells <clueTime>for 0 to 72 hours</clueTime>, followed by coincubation of oleate with human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate for a further 6 to 24 hours.</clue>
</event>
<event KT="Method" id="E11">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T17"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<event KT="Method" id="E12">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T18"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<event KT="Method" id="E13">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T19"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<event KT="Method" id="E14">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T20"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<event KT="Method" id="E15">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T22"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<event KT="Method" id="E16">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T16"/>
<theme idref="T23"/>
<clue>We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours, followed by <clueType>coincubation</clueType> <linkTheme>of</linkTheme> oleate <linkTheme>with</linkTheme> human recombinant tumor necrosis factor, interleukin (IL)-1alpha, IL-1beta, IL-4, Escherichia coli lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate <clueTime>for a further 6 to 24 hours</clueTime>.</clue>
</event>
<sentence id="S4">The <term id="T24" lex="endothelial_expression" sem="Other">endothelial expression</term> of <term id="T25" lex="vascular_cell_adhesion_molecule-1" sem="Protein_molecule">vascular cell adhesion molecule-1</term> (<term id="T26" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>), <term id="T27" lex="E-selectin" sem="Protein_molecule">E-selectin</term>, and <term id="T28" lex="intercellular_adhesion_molecule-1" sem="Protein_molecule">intercellular adhesion molecule-1</term> was monitored by <term id="T29" lex="cell_surface_enzyme_immunoassay" sem="Other">cell surface enzyme immunoassays</term> or <term id="T30" lex="flow_cytometry" sem="Other">flow cytometry</term>, and <term id="T31" lex="steady-state_level" sem="Other">steady-state levels</term> of <term id="T32" lex="VCAM-1_mRNA" sem="RNA_molecule">VCAM-1 mRNA</term> were assessed by <term id="T33" lex="Northern_blot_analysis" sem="Other">Northern blot analysis</term>.</sentence>
<event KT="Investigation" id="E17" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>The <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1), E-selectin, and intercellular adhesion molecule-1 was <clueExperiment><clueKT>monitored</clueKT> by cell surface enzyme immunoassays or flow cytometry</clueExperiment>, and steady-state levels of VCAM-1 mRNA were assessed by Northern blot analysis.</clue>
</event>
<event KT="Investigation" id="E18">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>The <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1), E-selectin, and intercellular adhesion molecule-1 was <clueExperiment><clueKT>monitored</clueKT> by cell surface enzyme immunoassays or flow cytometry</clueExperiment>, and steady-state levels of VCAM-1 mRNA were assessed by Northern blot analysis.</clue>
</event>
<event KT="Investigation" id="E19">
<type class="Gene_expression"/>
<theme idref="T28"/>
<clue>The <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1), E-selectin, and intercellular adhesion molecule-1 was <clueExperiment><clueKT>monitored</clueKT> by cell surface enzyme immunoassays or flow cytometry</clueExperiment>, and steady-state levels of VCAM-1 mRNA were assessed by Northern blot analysis.</clue>
</event>
<event KT="Investigation" id="E20" uncertainty="doubtful">
<type class="Transcription"/>
<theme idref="T32"/>
<clue>The endothelial expression of vascular cell adhesion molecule-1 (VCAM-1), E-selectin, and intercellular adhesion molecule-1 was monitored by cell surface enzyme immunoassays or flow cytometry, and steady-state <clueType>levels</clueType> <linkTheme>of</linkTheme> VCAM-1 mRNA were <clueKT>assessed</clueKT> <clueExperiment>by Northern blot analysis</clueExperiment>.</clue>
</event>
<sentence id="S5">At 10 to 100 micromol/L for &gt;24 hours, <term id="T34" lex="oleate" sem="Organic_compound_other">oleate</term> inhibited the expression of all <term id="T35" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term> tested.</sentence>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T34"/>
<clue>At 10 to 100 micromol/L <clueTime>for &gt;24 hours</clueTime>, oleate <clueType>inhibited</clueType> the expression of all adhesion molecules tested.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T34"/>
<clue>At 10 to 100 micromol/L <clueTime>for &gt;24 hours</clueTime>, oleate <clueType>inhibited</clueType> the expression of all adhesion molecules tested.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T34"/>
<clue>At 10 to 100 micromol/L <clueTime>for &gt;24 hours</clueTime>, oleate <clueType>inhibited</clueType> the expression of all adhesion molecules tested.</clue>
</event>
<event KT="Other" id="E24">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>At 10 to 100 micromol/L for &gt;24 hours, oleate inhibited the <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>all adhesion molecules tested</corefTheme>.</clue>
</event>
<event KT="Other" id="E25">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>At 10 to 100 micromol/L for &gt;24 hours, oleate inhibited the <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>all adhesion molecules tested</corefTheme>.</clue>
</event>
<event KT="Other" id="E26">
<type class="Gene_expression"/>
<theme idref="T28"/>
<clue>At 10 to 100 micromol/L for &gt;24 hours, oleate inhibited the <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>all adhesion molecules tested</corefTheme>.</clue>
</event>
<sentence id="S6">After a 72-hour incubation with <term id="T36" lex="oleate" sem="Lipid">oleate</term> and a further 16-hour incubation with <term id="T37" lex="oleate" sem="Lipid">oleate</term> plus 1 microg/mL <term id="T38" lex="LPS" sem="Lipid">LPS</term>, <term id="T39" lex="VCAM-1_expression" sem="Other"><term id="T40" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> expression</term> was reduced by &gt;40% compared with control.</sentence>
<event Manner="High" id="E27">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="E28"/>
<cause idref="E29"/>
<clue><linkCause>After</linkCause> a 72-hour incubation with oleate and a further 16-hour incubation with oleate plus 1 microg/mL LPS, VCAM-1 expression was <clueType>reduced</clueType> <clueManner>by &gt;40%</clueManner> compared with control.</clue>
</event>
<event KT="Method" id="E28">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T36"/>
<clue>After a <clueTime>72-hour</clueTime> <clueType>incubation</clueType> <linkTheme>with</linkTheme> oleate and a further 16-hour incubation with oleate plus 1 microg/mL LPS, VCAM-1 expression was reduced by &gt;40% compared with control.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Method" id="E29">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T37"/>
<theme idref="T38"/>
<clue>After a 72-hour incubation with oleate and a <clueTime>further 16-hour</clueTime> <clueType>incubation</clueType> <linkTheme>with</linkTheme> oleate plus 1 microg/mL LPS, VCAM-1 expression was reduced by &gt;40% compared with control.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E30">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>After a 72-hour incubation with oleate and a further 16-hour incubation with oleate plus 1 microg/mL LPS, VCAM-1 <clueType>expression</clueType> was reduced by &gt;40% compared with control.</clue>
</event>
<sentence id="S7">Adhesion of <term id="T41" lex="monocytoid_U937_cell" sem="Cell_cultured">monocytoid U937 cells</term> to <term id="T42" lex="LPS-treated_endothelial_cell" sem="Cell_cultured"><term id="T43" lex="LPS" sem="Lipid">LPS</term>-treated <term id="A2" sem="Cell_natural">endothelial cells</term></term> was reduced concomitantly.</sentence>
<event id="E31">
<type class="Cell_adhesion"/>
<theme idref="T41"/>
<theme idref="T42"/>
<clue><clueType>Adhesion</clueType> <linkTheme>of</linkTheme> monocytoid U937 cells <linkTheme>to</linkTheme> LPS-treated endothelial cells was reduced concomitantly.</clue>
<comment>NER: T42 sem mod, Other_name -&gt; Cell_line</comment></event>
<event KT="Method" id="E32">
<type class="Artificial_process"/>
<theme idref="A2"/>
<theme idref="T43"/>
<clue>Adhesion of monocytoid U937 cells to LPS-<clueType>treated</clueType> endothelial cells was reduced concomitantly.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<clue>Adhesion of monocytoid U937 cells to LPS-treated endothelial cells was <clueType>reduced</clueType> concomitantly.</clue>
</event>
<event id="E50">
<type class="Correlation"/>
<theme idref="E27"/>
<theme idref="E33"/>
<clue>Adhesion of monocytoid U937 cells to LPS-treated endothelial cells was reduced <clueType>concomitantly</clueType>.</clue>
</event>
<sentence id="S8"><term id="T44" lex="oleate" sem="Lipid">Oleate</term> also produced a quantitatively similar reduction of <term id="T45" lex="VCAM-1_mRNA_level" sem="Other"><term id="T46" lex="VCAM-1_mRNA" sem="RNA_molecule"><term id="T47" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> mRNA</term> levels</term> on <term id="T48" lex="Northern_blot_analysis" sem="Other">Northern blot analysis</term> and inhibited <term id="T49" lex="nuclear_factor-kappaB_activation" sem="Other"><term id="T50" lex="nuclear_factor-kappaB" sem="Protein_molecule">nuclear factor-kappaB</term> activation</term> on <term id="T51" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term>.</sentence>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="T46"/>
<cause idref="T44"/>
<clue>Oleate also produced a quantitatively similar <clueType>reduction</clueType> <linkTheme>of</linkTheme> VCAM-1 mRNA levels <clueExperiment>on Northern blot analysis</clueExperiment> and inhibited nuclear factor-kappaB activation on electrophoretic mobility shift assays.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E36"/>
<cause idref="T44"/>
<clue>Oleate also produced a quantitatively similar reduction of VCAM-1 mRNA levels on Northern blot analysis and <clueType>inhibited</clueType> nuclear factor-kappaB activation <clueExperiment>on electrophoretic mobility shift assays</clueExperiment>.</clue>
</event>
<event KT="Other" id="E36">
<type class="Positive_regulation"/>
<theme idref="T50"/>
<clue>Oleate also produced a quantitatively similar reduction of VCAM-1 mRNA levels on Northern blot analysis and inhibited nuclear factor-kappaB <clueType>activation</clueType> on electrophoretic mobility shift assays.</clue>
</event>
<sentence id="S9">Incubation of <term id="T52" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term> with <term id="T53" lex="oleate" sem="Lipid">oleate</term> for 72 hours decreased the relative proportions of <term id="T54" lex="saturated_(palmitic_and_stearic)_acid" sem="Lipid">saturated (palmitic and stearic) acids</term> in total <term id="T55" lex="cell_lipid" sem="Lipid">cell lipids</term> and increased the proportions of <term id="T56" lex="oleate" sem="Organic_compound_other">oleate</term> in total <term id="T57" lex="cell_lipid" sem="Lipid">cell lipids</term> without significantly changing the relative proportions of <term id="T58" lex="polyunsaturated_fatty_acid" sem="Lipid">polyunsaturated fatty acids</term>.</sentence>
<event KT="Method" id="E37">
<type class="Artificial_process"/>
<theme idref="T52"/>
<theme idref="T53"/>
<clue><clueType>Incubation</clueType> <linkTheme>of</linkTheme> endothelial cells <linkTheme>with</linkTheme> oleate <clueTime>for 72 hours</clueTime> decreased the relative proportions of saturated (palmitic and stearic) acids in total cell lipids and increased the proportions of oleate in total cell lipids without significantly changing the relative proportions of polyunsaturated fatty acids.</clue>
</event>
<event id="E38">
<type class="Negative_regulation"/>
<theme idref="T54"/>
<cause idref="E37"/>
<clue>Incubation of endothelial cells with oleate for 72 hours <clueType>decreased</clueType> the relative proportions of saturated (palmitic and stearic) acids in total cell lipids and increased the proportions of oleate in total cell lipids without significantly changing the relative proportions of polyunsaturated fatty acids.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="E37"/>
<clue>Incubation of endothelial cells with oleate for 72 hours decreased the relative proportions of saturated (palmitic and stearic) acids in total cell lipids and <clueType>increased</clueType> the proportions of oleate in total cell lipids without significantly changing the relative proportions of polyunsaturated fatty acids.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E40">
<type class="Regulation"/>
<theme idref="T58"/>
<cause idref="E37"/>
<clue>Incubation of endothelial cells with oleate for 72 hours decreased the relative proportions of saturated (palmitic and stearic) acids in total cell lipids and increased the proportions of oleate in total cell lipids <cluePolarity>without</cluePolarity> <clueManner>significantly</clueManner> <clueType>changing</clueType> the relative proportions <linkTheme>of</linkTheme> polyunsaturated fatty acids.</clue>
</event>
<sentence id="S10">Although less potent than <term id="T59" lex="polyunsaturated_fatty_acid" sem="Lipid">polyunsaturated fatty acids</term> in inhibiting <term id="T60" lex="endothelial_activation" sem="Other">endothelial activation</term>, <term id="T61" lex="oleic_acid" sem="Lipid">oleic acid</term> may contribute to the prevention of <term id="T62" lex="atherogenesis" sem="Other">atherogenesis</term> through <term id="T63" lex="selective_displacement" sem="Other">selective displacement</term> of <term id="T64" lex="saturated_fatty_acid" sem="Lipid">saturated fatty acids</term> in <term id="T65" lex="cell_membrane_phospholipid" sem="Lipid">cell membrane phospholipids</term> and a consequent modulation of <term id="T66" lex="gene_expression" sem="Other">gene expression</term> for <term id="A4" sem="Protein_family_or_group">molecules</term> involved in <term id="T67" lex="monocyte_recruitment" sem="Other"><term id="A3" sem="Cell_natural">monocyte</term> recruitment</term>.</sentence>
<event id="E41" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T60"/>
<cause idref="T61"/>
<clue>Although less potent than polyunsaturated fatty acids in <clueType>inhibiting</clueType> endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event CL="L1" KT="Analysis" id="E42">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E44"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid <clueKT><clueCL>may</clueCL></clueKT> <clueType>contribute</clueType> <linkTheme>to</linkTheme> the prevention of atherogenesis <linkCause>through</linkCause> selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event CL="L1" KT="Analysis" id="E45">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E46"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid <clueKT><clueCL>may</clueCL></clueKT> <clueType>contribute</clueType> <linkTheme>to</linkTheme> the prevention of atherogenesis <linkCause>through</linkCause> selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event KT="Other" id="E43">
<type class="Negative_regulation"/>
<theme idref="T62"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the <clueType>prevention</clueType> <linkTheme>of</linkTheme> atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event KT="Other" id="E44">
<type class="Negative_regulation"/>
<theme idref="T64"/>
<cause idref="T61"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective <clueType>displacement</clueType> <linkTheme>of</linkTheme> saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="T61"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent <clueType>modulation</clueType> <linkTheme>of</linkTheme> gene expression for molecules involved in monocyte recruitment.</clue>
</event>
<event KT="Other" id="E47">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of <clueType>gene expression</clueType> <linkTheme>for</linkTheme> molecules involved in monocyte recruitment.</clue>
</event>
<event KT="Other" id="E48">
<type class="Regulation"/>
<theme idref="E49"/>
<cause idref="A4"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules <clueType>involved</clueType> <linkTheme>in</linkTheme> monocyte recruitment.</clue>
</event>
<event KT="Other" id="E49">
<type class="Cell_adhesion"/>
<theme idref="A3"/>
<clue>Although less potent than polyunsaturated fatty acids in inhibiting endothelial activation, oleic acid may contribute to the prevention of atherogenesis through selective displacement of saturated fatty acids in cell membrane phospholipids and a consequent modulation of gene expression for molecules involved in monocyte <clueType>recruitment</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
